Drug maker Novartis announces $5 bn bond issue
Drug maker Novartis announces $5 bn bond issue
Basel, Switzerland: Swiss drug maker Novartis AG announced Wednesday a $5 billion bond issue to finance its purchase of eye-care company Alcon Inc.
The pharmaceuticals company said the notes will be issued in three parts by its US subsidiary Novartis Capital Corporation.
“Proceeds will be used for intercompany refinancing purposes in connection with the pending Alcon acquisition, as well as for general corporate purposes," Novartis said in a statement.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!